Aryl hydrocarbon receptor-mediated effects of 2,3,7,8-tetrachlorodibenzo-p- dioxin on glucose-stimulated insulin secretion in mice

Journal of Applied Toxicology

Volumn 29, Issue 8, 2009, Pages 689-694

  Kurita, Hisaka ^a   Yoshioka, Wataru ^a   Nishimura, Noriko ^b   Kubota, Naoto ^a   Kadowaki, Takashi ^a   Tohyama, Chiharu ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

Author keywords

Aryl hydrocarbon receptor; Dioxin; Glucose; Insulin; Islets of Langerhans

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EX VIVO STUDY; EXPERIMENTAL MODEL; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD GLUCOSE; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN;

MUS;

EID: 74549218060     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1459     Document Type: Article

References (38)

1. Adachi T, Yasuda K, Mori C, Yoshinaga M, Aoki N, Tsujimoto G, Tsuda K. 2005. Promoting insulin secretion in pancreatic islets by means of bisphenol A and nonylphenol via intracellular estrogen receptors. Food Chem. Toxicol. 43(5): 713-719.
2. Aizawa T, Komatsu M. 2005. Rab27a: a new face in beta cell metabolism-secretion coupling. J. Clin. Invest. 115(2): 227-230.
3. Bertazzi PA, Bernucci I, Brambilla G, Consonni D, Pesatori AC. 1998. The Seveso studies on early and long-term eff ects of dioxin exposure: a review. Environ. Health Perspect. 106(suppl. 2): 625-633.
4. Berthoud HR, Jeanrenaud B. 1979. Acute hyperinsulinemia and its reversal by vagotomy after lesions of the ventromedial hypothalamus in anesthetized rats. Endocrinology 105(1): 146-151.
5. Butler RA, Kelley ML, Powell WH, Hahn ME, Van Beneden RJ. 2001. An aryl hydrocarbon receptor (AHR) homologue from the soft-shell clam, Mya arenaria: evidence that invertebrate AHR homologues lack 2,3,7,8-tetrachlorodibenzo-p-dioxin and [beta]-naphthofl avone binding. Gene 278(1-2): 223-234.
6. Chen YW, Huang CF, Tsai KS, Yang RS, Yen CC, Yang CY, Lin-Shiau SY, Liu SH. 2006. The role of phosphoinositide 3-kinase/Akt signaling in low-dose mercury-induced mouse pancreatic {beta}-cell dysfunction in vitro and in vivo. Diabetes 55(6): 1614-1624.
7. Dong B, Matsumura F. 2008. Roles of Cytosolic Phospholipase A2 and Src kinase in the early action of 2,3,7,8-tetrachlorodibenzo-p-dioxin through a nongenomic pathway in MCF10A cells. Mol. Pharmacol. 74(1): 255-263.
8. Enan E, Liu PC, Matsumura F. 1992. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes reduction of glucose transporting activities in the plasma membranes of adipose tissue and pancreas from the guinea pig. J. Biol. Chem. 267(28): 19785-19791.
9. Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ. 1996. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 140(1): 173-179.
10. Gonzalez FJ, Fernandez-Salguero P. 1998. The aryl hydrocarbon receptor. studies using the AHR-null mice. Drug Metab. Dispos. 26(12): 1194-1198.
11. Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, O'Connell PJ, Gonzalez FJ, Kahn CR. 2005. Loss of ARNT/HIF1beta mediates altered gene expression and pancreaticislet dysfunction in human type 2 diabetes. Cell 122(3): 337-349.
12. Hahn ME, Karchner SI, Shapiro MA, Perera SA. 1997. Molecular evolution of two vertebrate aryl hydrocarbon (dioxin) receptors (AHR1 and AHR2) and the PAS family. Proc. Natl Acad. Sci. USA 94(25): 13743-13748.
13. Hanneman WH, Legare ME, Barhoumi R, Burghardt RC, Safe S, Tiffany-castiglioni E. 1996. Stimulation of calcium uptake in cultured rat hippocampal neurons by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 112(1): 19-28.
14. Henriksen GL, Ketchum NS, Michalek JE, Swaby JA. 1997. Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand. Epidemiology 8(3): 252-258.
15. Ishida T, Kan-o S, Mutoh J, Takeda S, Ishii Y, Hashiguchi I, Akamine A, Yamada H. 2005. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced change in intestinal function and pathology: evidence for the involvement of arylhydrocarbon receptor-mediated alteration of glucose transportation. Toxicol. Appl. Pharmacol. 205(1): 89-97.
16. Ithakissios DS, Ghafghazi T, Mennear JH, Kessler WV. 1975. Eff ect of multiple doses of cadmium on glucose metabolism and insulin secretion in the rat. Toxicol. Appl. Pharmacol. 31(1): 143-149.
17. Jijakli H, Malaisse WJ. 1998. Verapamil- and cadmium-resistant stimulation of calcium uptake and insulin release by -glucose in depolarised pancreatic islets exposed to diazoxide. Cell. Signall. 10(9): 661-665.
18. Kahn SE, Hull RL, Utzschneider KM. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444(7121): 840-846.
19. Kern PA, Said S, Jackson WG, Jr., Michalek JE. 2004. Insulin sensitivity following agent orange exposure in Vietnam veterans with high blood levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Clin. Endocrinol. Metab. 89(9): 4665-4672.
20. Kim S-Y, Lee H-G, Choi E-J, Park K-Y, Yang J-H. 2007. TCDD alters PKC signaling pathways in developing neuronal cells in culture. Chemosphere 67(9): S421-S427.
21. Lahvis GP, Lindell SL, Thomas RS, McCuskey RS, Murphy C, Glover E, Bentz M, Southard J, Bradfi eld CA. 2000. Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-defi cient mice. Proc. Natl Acad. Sci. USA 97(19): 10442-10447.
22. Michalek JE, Pavuk M. 2008. Diabetes and cancer in veterans of Operation Ranch Hand after adjustment for calendar period, days of spraying, and time spent in Southeast Asia. J. Occup. Environ. Med. 50(3): 330-340.
23. Michalek JE, Akhtar FZ, Kiel JL. 1999. Serum dioxin, insulin, fasting glucose, and sex hormone-binding globulin in veterans of Operation Ranch Hand. J. Clin. Endocrinol. Metab. 84(5): 1540-1543.
24. Mimura J, Yamashita K, Nakamura K, Morita M, Takagi TN, Nakao K, Ema M, Sogawa K, Yasuda M, Katsuki M, Fujii-Kuriyama Y. 1997. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2(10): 645-654.
25. 2+ influx does not trigger glucose-induced traffic of the insulin granules and alteration of their distribution. Exp. Biol. Med. (Maywood) 228(10): 1218-1226.
26. Nilsson T, Rorsman F, Berggren P-O, Hellman B. 1986. Accumulation of cadmium in pancreatic [beta] cells is similar to that of calcium in being stimulated by both glucose and high potassium. Biochim. Biophys. Acta Mol. Cell Res. 888(3): 270-277.
27. Novelli M, Piaggi S, De Tata V. 2005. 2,3,7,8-Tetrachlorodibenzo -p-dioxininduced impairment of glucose-stimulated insulin secretion in isolated rat pancreatic islets. Toxicol. Lett. 156(2): 307-314.
28. Pesatori AC, Consonni D, Bachetti S, Zocchetti C, Bonzini M, Baccarelli A, Bertazzi PA. 2003. Short- and long-term morbidity and mortality in the population exposed to dioxin after the 'Seveso accident'. Ind. Health 41(3): 127-138.
29. Piaggi S, Novelli M, Martino L, Masini M, Raggi C, Orciuolo E, Masiello P, Casini A, De Tata V. 2007. Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the beta-cell line INS-1E. Toxicol. Appl. Pharmacol. 220(3): 333-340.
30. Porte D, Jr. 2001. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications. Diabet./Metab. Res. Rev 17(3): 181-188.
31. Puga A, Nebert DW, Carrier F. 1992. Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell Biol. 11(4): 269-281.
32. Schwartz GG, Il'yasova D, Ivanova A. 2003. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabet. Care 26(2): 468-470.
33. 2+ and cell proliferation in primary human mammary epithelial cells. Carcinogenesis 18(6): 1177-1182.
34. Thackaberry EA, Bedrick EJ, Goens MB, Danielson L, Lund AK, Gabaldon D, Smith SM, Walker MK. 2003. Insulin regulation in AhR-null mice: embryonic cardiac enlargement, neonatal macrosomia, and altered insulin regulation and response in pregnant and aging AhR-null females. Toxicol. Sci. 76(2): 407-417.
35. Tuomisto JT, Pohjanvirta R, Unkila M, Tuomisto J. 1995. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced anorexia and wasting syndrome in rats: aggravation after ventromedial hypothalamic lesion. Eur. J. Pharmacol. 293(4): 309-317.
36. Vena J, Boff etta P, Becher H, Benn T, Bueno-de-Mesquita HB, Coggon D, Colin D, Flesch-Janys D, Green L, Kauppinen T, Littorin M, Lynge E, Mathews JD, Neuberger M, Pearce N, Pesatori AC, Saracci R, Steenland K, Kogevinas M. 1998. Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers. Environ. Health Perspect. 106(suppl. 2): 645-653.
37. Weber LWD, Stahl BU, Lebofsky M, Alper RH, Kerecsen L, Rozman K. 1991. Inhibition of phosphoenolpyruvate carboxykinase activity appears to be the key biochemical lesion in the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Chemosphere 23(11-12): 1957-1962.
38. Wild S, Roglic G, Green A, Sicree R, King H. 2004. Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabet. Care 27(5): 1047-1053.